Pharmaceuticals in Canada
Summary
Pharmaceuticals in Canada industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The Canadian pharmaceuticals market had total revenues of $23,753.5m in 2019, representing a compound annual growth rate (CAGR) of 2.4% between 2015 and 2019.
- Health spending as a share of Canada’s gross domestic product (GDP) is trending upward, with expenditures representing around 11.6% of Canada’s GDP in 2019.
- Canada’s healthcare system is national, with universal coverage. Publically funded access programs are used by a third of Canadians, with the remainder having private insurance.
Scope
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Canada
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Canada
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Canada pharmaceuticals market with five year forecasts
Reasons to Buy
- What was the size of the Canada pharmaceuticals market by value in 2019?
- What will be the size of the Canada pharmaceuticals market in 2024?
- What factors are affecting the strength of competition in the Canada pharmaceuticals market?
- How has the market performed over the last five years?
- Who are the top competitiors in Canada's pharmaceuticals market?
Table of Contents
1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Market rivalry
1.6. Competitive Landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
4 Market Segmentation
4.1. Geography segmentation
5 Market Outlook
5.1. Market value forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Market share
7.2. Who are the leading players?
7.3. What are the strengths/weaknesses of leading players?
7.4. What strategies do leading players follow?
7.5. How does government regulation impact leading players?
7.6. What impact is COVID-19 having on the market?
8 Company Profiles
8.1. Johnson & Johnson
8.2. Pfizer Inc.
8.3. Apotex Pharmachem Inc
8.4. Merck & Co., Inc.
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
List of Tables
List of Tables
Table 1: Canada pharmaceuticals market value: $ billion, 2015-19
Table 2: Canada pharmaceuticals market geography segmentation: $ billion, 2019
Table 3: Canada pharmaceuticals market value forecast: $ billion, 2019-24
Table 4: Canada pharmaceuticals market share: % share, by value, 2019
Table 5: Johnson & Johnson: key facts
Table 6: Johnson & Johnson: Annual Financial Ratios
Table 7: Johnson & Johnson: Key Employees
Table 8: Johnson & Johnson: Key Employees Continued
Table 9: Pfizer Inc.: key facts
Table 10: Pfizer Inc.: Annual Financial Ratios
Table 11: Pfizer Inc.: Key Employees
Table 12: Pfizer Inc.: Key Employees Continued
Table 13: Apotex Pharmachem Inc: key facts
Table 14: Apotex Pharmachem Inc: Key Employees
Table 15: Merck & Co., Inc.: key facts
Table 16: Merck & Co., Inc.: Annual Financial Ratios
Table 17: Merck & Co., Inc.: Key Employees
Table 18: Merck & Co., Inc.: Key Employees Continued
Table 19: Canada size of population (million), 2015-19
Table 20: Canada gdp (constant 2005 prices, $ billion), 2015-19
Table 21: Canada gdp (current prices, $ billion), 2015-19
Table 22: Canada inflation, 2015-19
Table 23: Canada consumer price index (absolute), 2015-19
Table 24: Canada exchange rate, 2015-19
List of Figures
List of Figures
Figure 1: Canada pharmaceuticals market value: $ billion, 2015-19
Figure 2: Canada pharmaceuticals market geography segmentation: % share, by value, 2019
Figure 3: Canada pharmaceuticals market value forecast: $ billion, 2019-24
Figure 4: Forces driving competition in the pharmaceuticals market in Canada, 2019
Figure 5: Drivers of buyer power in the pharmaceuticals market in Canada, 2019
Figure 6: Drivers of supplier power in the pharmaceuticals market in Canada, 2019
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Canada, 2019
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in Canada, 2019
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in Canada, 2019
Figure 10: Canada pharmaceuticals market share: % share, by value, 2019
Johnson & Johnson
Pfizer Inc.
Apotex Pharmachem Inc
Merck & Co., Inc.
*If Applicable.